Literature DB >> 2870021

Relationship between non-antigen-specific immunodepression and persisting immune complexes induced by pertussis in mice.

S Grace, D M De Villiers, N M Almond, C J Elson.   

Abstract

A temporal relationship has been demonstrated between persisting immune complexes and non-antigen-specific immunodepression. Mice were given intraperitoneal injections of Bordetella pertussis at weekly intervals. After 7 weeks they developed circulating immune complexes, the levels of which increased with continued administration of pertussis. The increase in immune complex levels was accompanied by a diminished primary immune response to intraperitoneally injected sheep erythrocytes (SRBC) as judged by a reduction in their direct and indirect plaque-forming cell response and serum agglutination titres. Spleen cells from immunodepressed pertussis-treated mice were transferred to irradiated normal recipients and displayed a normal response to SRBC. By contrast, spleen cells transferred from normal donors to irradiated pertussis-treated recipients had an impaired response to SRBC. Thus, the immunodepression caused by pertussis treatment is a property of the environment and not the lymphocytes themselves. It is considered that chronic circulating immune complexes induced by pertussis administration may cause non-antigen-specific immunodepression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870021      PMCID: PMC1453862     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  The effect of pertussis vaccine on the immune response of mice to sheep red blood cells.

Authors:  D W Dresser; H H Wortis; H R Anderson
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

2.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 3.  Suppressor cells in humoral immunity and tolerance.

Authors:  R B Taylor; A Basten
Journal:  Br Med Bull       Date:  1976-05       Impact factor: 4.291

4.  Clearance and localization of immunoglobulin oligomers in mice with chronic circulating endogenous complexes.

Authors:  S A Grace; F M Brennan
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

5.  Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.

Authors:  A B Gottlieb; R G Lahita; N Chiorazzi; H G Kunkel
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

Authors:  S A Grace; C J Elson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

7.  Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis.

Authors:  F G Germuth; E Rodriguez; C A Lorelle; E I Trump; L Milano; O Wise
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

8.  Clearance and organ localization of particles and soluble complexes in mice with circulating complexes.

Authors:  S D Carter; F M Brennan; S A Grace; C J Elson
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

9.  Cell-mediated immunity in rheumatoid arthritis.

Authors:  A A Andrianakos; J T Sharp; D A Person; M D Lidsky; J Duffy
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

10.  The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor.

Authors:  R D Stout; L A Herzenberg
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  1 in total

1.  Antibody producing capacity to the bacteriophage phi X174 in rheumatoid arthritis.

Authors:  R Bucknall; P Bacon; C Elson; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.